Zhishu Gong
Zhengzhou People's Hospital(CN)
Research Areas
Silicon Carbide Semiconductor Technologies, Virus-based gene therapy research, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Toxin Mechanisms and Immunotoxins
Most-Cited Works
- → Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells(2016)151 cited
- → Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells(2016)51 cited